| Phase 4 |
| NCT06802926 |
Pilot Trial of Colchicine for Graft Failure in CABG |
CABG |
Recruiting |
| NCT06818084 |
TRanscAtheter TreatMent of PurE Aortic Regurgitation With VitaFlow Liberty System |
AORTIC VALVE DISEASES |
Recruiting |
| NCT04310995 |
Different Anti-Spastic Therapy Strategies After CABG Using Radial Artery Grafts |
Coronary Artery Bypass Graft |
Active, Not Recruiting |
| NCT07558811 |
Effects of Glucocorticoid Therapy on Renal Function in Patients With PA Complicated by… |
Primary Aldosteronism Due to Adrenal Hyperplasia |
Not Yet Recruiting |
| Phase 3 |
| NCT07366528 |
Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer |
Gastric Cancer (GC) |
Recruiting |
| NCT07511127 |
Comparing the Efficacy of Different Durations of Maribavir Treatment Regimens in Allo-HSCT |
Hematologic Malignancy |
Recruiting |
| NCT05018520 |
The Safety and Effectiveness of 4R-CHOP+4R vs 6R-CHOP+2R in Newly Diagnosed Patients With… |
Diffuse Large B Cell Lymphoma |
Recruiting |
| NCT07511114 |
A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated… |
DLBCL - Diffuse Large B Cell Lymphoma |
Not Yet Recruiting |
| Phase 2/3 |
| NCT04208347 |
Perioperative Treatment of Combined SOX With Apatinib and Camrelizumab for… |
Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma |
Active, Not Recruiting |
| Phase 2 |
| NCT07306273 |
IRE Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC… |
Pancreatic Adenocarcinoma Locally Advanced |
Recruiting |
| NCT07306286 |
Cryoablation Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of… |
Pancreatic Adenocarcinoma Locally Advanced |
Recruiting |
| NCT06365671 |
CAR-T Following ASCT for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (R/R B-NHL)… |
B-cell Non Hodgkin Lymphoma |
Recruiting |
| NCT06519591 |
Systemic Application of Cadonilimab, LM-302, and S-1 Combined With Intraperitoneal… |
Gastric Cancer Stage IV |
Recruiting |
| NCT07380984 |
PD-1 Antibody-based Therapy With Concurrent RT for Early-stage NKTCL |
Natural Killer/T-cell Lymphoma |
Recruiting |
| NCT06793189 |
MZL-IPI Risk-adapted Targeted Therapy in Untreated MZL |
Marginal Zone Lymphoma(MZL) |
Recruiting |
| NCT07331883 |
Sintilimab Combined With Bevacizumab Biosimilar as Adjuvant Treatment After Resection of… |
Hepatocellular Carcinoma (HCC) |
Recruiting |
| NCT07504471 |
Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and… |
Pancreatic Neoplasms |
Recruiting |
| NCT07556640 |
LM-302 and S-1 Plus Intraperitoneal Paclitaxel With or Without Cadonilimab for Claudin… |
Gastric Cancer Stage IV |
Recruiting |
| NCT07569068 |
Neoadjuvant Tislelizumab + LM-302 + S-1 or Tislelizumab + SOX for CLDN18.2-Positive… |
Gastric or Esophagogastric Junction Adenocarcinoma |
Recruiting |
| NCT07514169 |
The Efficacy and Safety of Pola-ZR-Glo in Older Treatment-naive Patients With LBCL |
Large B-Cell Lymphoma (LBCL) |
Recruiting |
| NCT07607418 |
Ivosidenib as Maintenance Therapy in Transplant-Ineligible IDH1-mutated AML and HR-MDS |
AML (Acute Myeloid Leukemia) |
Recruiting |
| NCT06587061 |
HRS-4642 in Combination With AG for Neoadjuvant and Adjuvant Treatment of Pancreatic… |
Pancreatic Cancer |
Recruiting |
| NCT07131514 |
HRS-4642 in Combination With Gemcitabine and Albumin-bound Paclitaxel and Adebrelimab for… |
Pancreatic Cancer |
Recruiting |
| NCT07548710 |
Study of SA+X in the Treatment of Newly Diagnosed AML |
Acute Myeloid Leukemia |
Recruiting |
| NCT07628738 |
A Prospective Clinical Study on Reduced-intensity Radiotherapy for Stage I/II Low-risk… |
Lymphoma (Non-Hodgkin's Lymphoma) |
Recruiting |